"Proton Pump Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.
| Descriptor ID |
D054328
|
| MeSH Number(s) |
D27.505.519.389.848
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proton Pump Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Proton Pump Inhibitors".
This graph shows the total number of publications written about "Proton Pump Inhibitors" by people in this website by year, and whether "Proton Pump Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 2 | 3 | 5 |
| 2005 | 3 | 1 | 4 |
| 2006 | 2 | 2 | 4 |
| 2007 | 4 | 1 | 5 |
| 2008 | 3 | 1 | 4 |
| 2009 | 4 | 7 | 11 |
| 2010 | 5 | 2 | 7 |
| 2011 | 5 | 3 | 8 |
| 2012 | 5 | 6 | 11 |
| 2013 | 4 | 6 | 10 |
| 2014 | 4 | 3 | 7 |
| 2015 | 15 | 5 | 20 |
| 2016 | 11 | 7 | 18 |
| 2017 | 8 | 6 | 14 |
| 2018 | 10 | 5 | 15 |
| 2019 | 11 | 4 | 15 |
| 2020 | 9 | 3 | 12 |
| 2021 | 7 | 2 | 9 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proton Pump Inhibitors" by people in Profiles.
-
Assimon MM, Pun PH, Al-Khatib SM, Brookhart MA, Gaynes BN, Winkelmayer WC, Flythe JE. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 Jun; 31(6):670-679.
-
Fass R, Boeckxstaens GE, El-Serag H, Rosen R, Sifrim D, Vaezi MF. Gastro-oesophageal reflux disease. Nat Rev Dis Primers. 2021 07 29; 7(1):55.
-
Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology. 2021 10; 74(4):2021-2031.
-
Wang X, Liu Q, Halfdanarson ÓÖ, Zoega H, Sadr-Azodi O, Engstrand L, Fall K, Brusselaers N. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study. Br J Cancer. 2021 09; 125(6):893-900.
-
Rokkas T, Gisbert JP, Malfertheiner P, Niv Y, Gasbarrini A, Leja M, Megraud F, O'Morain C, Graham DY. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. Gastroenterology. 2021 08; 161(2):495-507.e4.
-
Chiang TH, Chen CC, Tseng PH, Liou JM, Wu MS, Shun CT, Lee YC, Graham DY. Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study. Helicobacter. 2021 Jun; 26(3):e12801.
-
Pilotto V, Maddalo G, Orlando C, Fassan M, Rugge M, Farinati F, Savarino EV. Objective Evidence of Gastro-Esophageal Reflux Disease is Rare in Patients with Autoimmune Gastritis. J Gastrointestin Liver Dis. 2021 Mar 13; 30(1):30-36.
-
Brusselaers N, Sadr-Azodi O, Engstrand L. Proton pump inhibitors and the risk of pancreatic cancer. J Gastroenterol. 2021 03; 56(3):295-296.
-
Howden CW, Graham DY. Recent Developments Pertaining to H. pylori Infection. Am J Gastroenterol. 2021 01 01; 116(1):1-3.
-
Azhar M, Fiedler L, Espinosa PS, Hennekens CH. Proton Pump Inhibitors and Risk of Dementia: A Hypothesis Generated but Not Adequately Tested. Am J Alzheimers Dis Other Demen. 2021 Jan-Dec; 36:15333175211062413.